Clinical Trials Logo

Clinical Trial Summary

To investigate a new method to rapidly modulate pulmonary venous hemoglobin oxygen saturation to enable the use of deoxyhemoglobin concentration in arterial blood as an intra-arterial MRI contrast agent for cerebral tissue perfusion imaging.


Clinical Trial Description

Cerebral tissue perfusion can be examined by tracking a tracer through the cerebral vasculature. Currently, This requires an infusion of the contrast agent. However, advancements have been made in developing non-invasive imaging techniques to evaluate tissue perfusion. Magnetic resonance imaging (MRI) is a highly attractive imaging approach as it does not rely on ionizing radiation and has high spatial resolution. The common contrast agent used to study cerebral tissue perfusion in MRI is gadolinium-based contrast agents. However, these contrast agents tend to have several disadvantages including invasiveness, renal toxicity, tissue accumulation, and allergic reactions. As they are injected intravenously, they become highly dispersed in the arteries, requiring a complex computation of the arterial input function. In addition, although they remain predominantly intravascular, they tend to diffuse extravascular in neurovascular conditions which have a breakdown of the blood brain barrier leading to measurement inaccuracies. Recently we have determined a way to generate an abrupt change in deoxyhemoglobin concentration [dHb] as the blood passes the lungs, resulting in a precise and rapid targeted change of [dHb] in the arterial blood. We hypothesize that such changes in [dHb] may be used as a suitable MRI contrast agent for the measurement of cerebral blood flow, cerebral blood volume, and mean transit time (CBF, CBV and MTT respecrively) in comparison to that with gadolinium. If suitable, dOHb would provide a non-invasive, inexpensive, and safe alternative to perfusion imaging. A total of 25 patients with neurovascular disease who are clinically referred to the TWH Joint Department of Medical Imaging for gadolinium perfusion imaging will be recruited. Prior to the imaging study each subject will be familiarized with the respiratory gas control experimental setup. A plastic face mask and breathing circuit will be applied to the subject's face and fitted to form an airtight seal with medical adhesive tape. Gas supply to the mask and breathing circuit will be supplied by a programmable computer-controlled gas delivery system (RespirActâ„¢ RA-MR System, Thornhill Research Inc., Toronto, Canada). The sequence of gas delivery and changes in PCO2 and PO2 will be applied to familiarize the subject with the sensations related to changes in the gases. Subjects will then be placed supine in the MRI scanner. In addition to their prescribed clinical scans, two additional scans will be obtained. The additional MRI scans will include: 1) a structural (anatomical) sequence (4.30 minutes), followed by 2) a BOLD-EPI sequence while inducing changes of PO2. PO2 will be held at a baseline of 45-50 mmHg (hemoglobin O2 saturation, SaO2 ~75%) for 60s. For 10 s, the lung PO2 will be transiently raised to peak PO2 of 90-120 mmHg (normoxia) within 2 s transition, reaching a SaO2 of ~100%, and then returned to baseline. Alternatively, the baseline may be at normoxia and the gas challenges will target PO2 of 45-50 mmHg. A total of 4 such ventilatory challenges will be applied over 6 min while maintaining normocapnia. During each PO2 stimulus, the BOLD signal will change in synchrony and inverse proportion to [dOHb]. An arterial input function will be measured by separating arterial, tissue, and venous voxels based on differences in [dOHb] bolus arrival times, amplitude of change, and correlation to changes in [dOHb] measured from [Hb] and calculation of SaO2 from end-tidal PO2. Arterial voxels, the first in the sequence of structures to receive the bolus, will be averaged to yield an arterial input function that will be deconvolved with the tissue signal. Whole brain maps of relative CBF, CBV, and MTT will be generated. Whole brain segmented gray matter and white matter average values for these metrics will be calculated and compared against the same metric values obtained using gadolinium perfusion imaging. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04537611
Study type Interventional
Source University Health Network, Toronto
Contact Joseph Fisher
Phone 416-710-6908
Email joe.fisher@utoronto.ca
Status Not yet recruiting
Phase N/A
Start date August 2021
Completion date March 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis